Cardio-vascular medicine

More than 90,000 km of arteries, veins and capillaries run through our body and provide the vital in and outflow of blood to the organs. The human vascular system is a key organ for all the tissues of our body: Where no blood flows, there is no life. Many diseases such as atherosclerosis are based on damages to these blood vessels. Diseased blood vessels, however, mean diseased organs. Disorders of heart, brain and kidney function, heart attacks and leg amputations as well as blindness can be the fatal consequences of these vascular injuries.
Likewise, it can give rise to pregnancy complications such as pre-eclampsia and gestational diabetes with often serious consequences for mother and child.

The “modern” lifestyle with little physical activity coupled with the excessive intake of unsuitable foods and also smoking contributes significantly to the fact that cardio-vascular diseases are the number one cause of death in Germany!
According to vascular specialists (angiologists), about 200 million people worldwide suffer from peripheral artery occlusive disease (PAOD) – more commonly known as “Intermittent claudication”.

6.7 million people in Germany suffer from diabetes mellitus and every year, half a million people with the most common form, type 2 diabetes, are added. The resulting consequences are an annual increase of about 40,000 more limb amputations, 2,000 new cases of blindness and 2,000 more people who require dialysis.
Vascular-associated widespread diseases are a significant public health problem in all countries of the world and of significant economic impact to society.

The EFVM is committed to preventive measures to combat vascular disease at its source. At the same time, the EFVM wants to bring modern vascular medical diagnostics and therapies to all those who are in need. Only then can follow-on complications of vascular diseases be reduced.

In the prevention of vascular diseases this means:

  • Establishment of a nationwide medical care amputation register
  • Conducting studies on arteriogenesis
  • Establish guidelines for improving vascular health
  • Organization of scientific conferences in the vascular medicine
  • Information events for patients on prevention